Trial Outcomes & Findings for Safety and Efficacy Evaluation of a New Contact Lens Disinfecting Solution in Gas Permeable Contact Lens Wearers (NCT NCT01912781)

NCT ID: NCT01912781

Last Updated: 2015-06-30

Results Overview

Worn study lenses were removed and evaluated for deposits. Deposits found on the lenses were defined using a 3-part classification system consisting of general visibility, the specific appearance and area covered. A lens was considered visibly clean if it had nondetectable films or deposits. One eye (study eye) contributed to the analysis.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

112 participants

Primary outcome timeframe

Day 7, Day 30, Day 60, Day 90

Results posted on

2015-06-30

Participant Flow

Subjects were recruited from 12 study centers located in the US.

Of the 112 enrolled, 2 subjects were exited as screen failures and 4 were discontinued prior to randomization. This reporting group includes all randomized subjects (106).

Participant milestones

Participant milestones
Measure
FID 120974A
Contact lens disinfecting solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Boston Simplus
Multi-action solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Overall Study
STARTED
71
35
Overall Study
COMPLETED
69
35
Overall Study
NOT COMPLETED
2
0

Reasons for withdrawal

Reasons for withdrawal
Measure
FID 120974A
Contact lens disinfecting solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Boston Simplus
Multi-action solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Overall Study
Withdrawal by Subject
2
0

Baseline Characteristics

Safety and Efficacy Evaluation of a New Contact Lens Disinfecting Solution in Gas Permeable Contact Lens Wearers

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
FID 120974A
n=71 Participants
Contact lens disinfecting solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Boston Simplus
n=35 Participants
Multi-action solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Total
n=106 Participants
Total of all reporting groups
Age, Continuous
52.9 years
STANDARD_DEVIATION 10.2 • n=5 Participants
50.5 years
STANDARD_DEVIATION 13.4 • n=7 Participants
52.1 years
STANDARD_DEVIATION 11.4 • n=5 Participants
Sex: Female, Male
Female
55 Participants
n=5 Participants
28 Participants
n=7 Participants
83 Participants
n=5 Participants
Sex: Female, Male
Male
16 Participants
n=5 Participants
7 Participants
n=7 Participants
23 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Day 7, Day 30, Day 60, Day 90

Population: This analysis population includes all subjects with data at visit.

Worn study lenses were removed and evaluated for deposits. Deposits found on the lenses were defined using a 3-part classification system consisting of general visibility, the specific appearance and area covered. A lens was considered visibly clean if it had nondetectable films or deposits. One eye (study eye) contributed to the analysis.

Outcome measures

Outcome measures
Measure
FID 120974A
n=69 Participants
Contact lens disinfecting solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Boston Simplus
n=35 Participants
Multi-action solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Percentage of Subjects With Visibly Clean Lenses
Day 90
30.4 percentage of subjects
31.4 percentage of subjects
Percentage of Subjects With Visibly Clean Lenses
Day 7
42.0 percentage of subjects
57.1 percentage of subjects
Percentage of Subjects With Visibly Clean Lenses
Day 30
29.0 percentage of subjects
42.9 percentage of subjects
Percentage of Subjects With Visibly Clean Lenses
Day 60
29.0 percentage of subjects
42.9 percentage of subjects

PRIMARY outcome

Timeframe: Day 7, Day 30, Day 60, Day 90

Population: This analysis population includes all randomized subjects. Here, "n" is the total number of subjects with crystalline deposits in each treatment group, respectively, by visit.

Worn study lenses were removed and evaluated for deposits. Deposits found on the lenses were defined using a 3-part classification system consisting of general visibility, the specific appearance and area covered: Type II = films or deposits visible only under special conditions, such as special illumination using an eyepiece of 7-10 times magnification, Type III = films or deposits readily visible on a dry lens under room lighting, with unaided eye, and Type IV = films or deposits obvious under room lighting, with unaided eye, when the lens is wet or dry. One eye (study eye) contributed to the analysis.

Outcome measures

Outcome measures
Measure
FID 120974A
n=71 Participants
Contact lens disinfecting solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Boston Simplus
n=35 Participants
Multi-action solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Percentage of Subjects With Crystalline Deposits by Type
Day 7, Type II, n=10, 5
90.0 percentage of subjects
80.0 percentage of subjects
Percentage of Subjects With Crystalline Deposits by Type
Day 7, Type III, n=10, 5
0.0 percentage of subjects
20.0 percentage of subjects
Percentage of Subjects With Crystalline Deposits by Type
Day 7, Type IV, n=10, 5
10.0 percentage of subjects
0.0 percentage of subjects
Percentage of Subjects With Crystalline Deposits by Type
Day 30, Type II, n=17, 3
70.6 percentage of subjects
100.0 percentage of subjects
Percentage of Subjects With Crystalline Deposits by Type
Day 30, Type III, n=17, 3
17.6 percentage of subjects
0.0 percentage of subjects
Percentage of Subjects With Crystalline Deposits by Type
Day 30, Type IV, n=17, 3
11.8 percentage of subjects
0.0 percentage of subjects
Percentage of Subjects With Crystalline Deposits by Type
Day 60, Type II, n=18, 8
61.1 percentage of subjects
87.5 percentage of subjects
Percentage of Subjects With Crystalline Deposits by Type
Day 60, Type III, n=18, 8
16.7 percentage of subjects
0.0 percentage of subjects
Percentage of Subjects With Crystalline Deposits by Type
Day 60, Type IV, n=18, 8
22.2 percentage of subjects
12.5 percentage of subjects
Percentage of Subjects With Crystalline Deposits by Type
Day 90, Type II, n=21, 10
61.9 percentage of subjects
60.0 percentage of subjects
Percentage of Subjects With Crystalline Deposits by Type
Day 90, Type III, n=21, 10
23.8 percentage of subjects
10.0 percentage of subjects
Percentage of Subjects With Crystalline Deposits by Type
Day 90, Type IV, n=21, 10
14.3 percentage of subjects
30.0 percentage of subjects

PRIMARY outcome

Timeframe: Day 7, Day 30, Day 60, Day 90

Population: This analysis population includes all randomized subjects. Here, "n" is the total number of subjects with film deposits in each treatment group, respectively, by visit.

Worn study lenses were removed and evaluated for deposits. Deposits found on the lenses were defined using a 3-part classification system consisting of general visibility, the specific appearance and area covered: Type II = films or deposits visible only under special conditions, such as special illumination using an eyepiece of 7-10 times magnification, Type III = films or deposits readily visible on a dry lens under room lighting, with unaided eye, and Type IV = films or deposits obvious under room lighting, with unaided eye, when the lens is wet or dry. One eye (study eye) contributed to the analysis.

Outcome measures

Outcome measures
Measure
FID 120974A
n=71 Participants
Contact lens disinfecting solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Boston Simplus
n=35 Participants
Multi-action solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Percentage of Subjects With Film Deposits by Type
Day 30, Type IV, n=47, 20
17.0 percentage of subjects
10.0 percentage of subjects
Percentage of Subjects With Film Deposits by Type
Day 7, Type II, n=40, 15
80.0 percentage of subjects
66.7 percentage of subjects
Percentage of Subjects With Film Deposits by Type
Day 7, Type III, n=40, 15
7.5 percentage of subjects
26.7 percentage of subjects
Percentage of Subjects With Film Deposits by Type
Day 7, Type IV, n=40, 15
12.5 percentage of subjects
6.7 percentage of subjects
Percentage of Subjects With Film Deposits by Type
Day 30, Type II, n=47, 20
72.3 percentage of subjects
80.0 percentage of subjects
Percentage of Subjects With Film Deposits by Type
Day 30, Type III, n=47, 20
10.6 percentage of subjects
10.0 percentage of subjects
Percentage of Subjects With Film Deposits by Type
Day 60, Type II, n=47, 20
74.5 percentage of subjects
80.0 percentage of subjects
Percentage of Subjects With Film Deposits by Type
Day 60, Type III, n=47, 20
21.3 percentage of subjects
5.0 percentage of subjects
Percentage of Subjects With Film Deposits by Type
Day 60, Type IV, n=47, 20
4.3 percentage of subjects
15.0 percentage of subjects
Percentage of Subjects With Film Deposits by Type
Day 90, Type II, n=45, 24
73.3 percentage of subjects
79.2 percentage of subjects
Percentage of Subjects With Film Deposits by Type
Day 90, Type III, n=45, 24
13.3 percentage of subjects
8.3 percentage of subjects
Percentage of Subjects With Film Deposits by Type
Day 90, Type IV, n=45, 24
13.3 percentage of subjects
12.5 percentage of subjects

PRIMARY outcome

Timeframe: Day 90/Early Exit

Population: This analysis population includes all randomized subjects.

Worn study lenses were removed and analyzed by high performance liquid chromatography (HPLC) for residual lens lysozyme (protein). Values reported as lower than the limit of quantitation or none detected were imputed as 0.5 μg or 0 μg, respectively. A lower value indicates less lysozyme deposition. One eye (study eye) contributed to the analysis.

Outcome measures

Outcome measures
Measure
FID 120974A
n=71 Participants
Contact lens disinfecting solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Boston Simplus
n=35 Participants
Multi-action solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Average Residual Lens Lysozyme
0.2 micrograms per lens
Standard Deviation 0.5
0.2 micrograms per lens
Standard Deviation 0.4

PRIMARY outcome

Timeframe: Baseline (Day 0), Day 7, Day 30, Day 60, Day 90

Population: This analysis population includes all subjects with data at visit.

Distance VA was assessed for each eye individually while reading a chart distant to the participant in dimmed room illumination. VA was measured using a Snellen chart, with 20/20 Snellen acuity considered normal distance-eyesight. A line increase indicates an improvement in VA. One eye (study eye) contributed to the analysis.

Outcome measures

Outcome measures
Measure
FID 120974A
n=69 Participants
Contact lens disinfecting solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Boston Simplus
n=35 Participants
Multi-action solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line Change
Day 7, 1 Line Decrease from Baseline
4.3 percentage of subjects
5.7 percentage of subjects
Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line Change
Day 90, 2 Line Decrease from Baseline
0.0 percentage of subjects
0.0 percentage of subjects
Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line Change
Day 60, 1 Line Increase from Baseline
1.4 percentage of subjects
2.9 percentage of subjects
Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line Change
Day 60, No Change from Baseline
97.1 percentage of subjects
94.3 percentage of subjects
Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line Change
Day 7, 2 Line Increase from Baseline
0.0 percentage of subjects
0.0 percentage of subjects
Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line Change
Day 7, 1 Line Increase from Baseline
2.9 percentage of subjects
0.0 percentage of subjects
Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line Change
Day 7, No Change from Baseline
92.8 percentage of subjects
94.3 percentage of subjects
Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line Change
Day 7, 2 Line Decrease from Baseline
0.0 percentage of subjects
0.0 percentage of subjects
Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line Change
Day 30, 2 Line Increase from Baseline
0.0 percentage of subjects
0.0 percentage of subjects
Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line Change
Day 30, 1 Line Increase from Baseline
1.4 percentage of subjects
0.0 percentage of subjects
Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line Change
Day 30, No Change from Baseline
95.7 percentage of subjects
97.1 percentage of subjects
Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line Change
Day 30, 1 Line Decrease from Baseline
2.9 percentage of subjects
2.9 percentage of subjects
Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line Change
Day 30, 2 Line Decrease from Baseline
0.0 percentage of subjects
0.0 percentage of subjects
Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line Change
Day 60, 2 Line Increase from Baseline
1.4 percentage of subjects
0.0 percentage of subjects
Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line Change
Day 60, 1 Line Decrease from Baseline
0.0 percentage of subjects
2.9 percentage of subjects
Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line Change
Day 60, 2 Line Decrease from Baseline
0.0 percentage of subjects
0.0 percentage of subjects
Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line Change
Day 90, 2 Line Increase from Baseline
0.0 percentage of subjects
2.9 percentage of subjects
Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line Change
Day 90, 1 Line Increase from Baseline
0.0 percentage of subjects
2.9 percentage of subjects
Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line Change
Day 90, No Change from Baseline
97.1 percentage of subjects
91.4 percentage of subjects
Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line Change
Day 90, 1 Line Decrease from Baseline
2.9 percentage of subjects
2.9 percentage of subjects

PRIMARY outcome

Timeframe: Day 7, Day 30, Day 60, Day 90

Population: This analysis population includes all subjects with data at visit.

Subject recorded a response to the question, "Averaging over the last 3 days, how many hours per day did you wear your contact lenses?" Lens wear time was measured in hours.

Outcome measures

Outcome measures
Measure
FID 120974A
n=69 Participants
Contact lens disinfecting solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Boston Simplus
n=35 Participants
Multi-action solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Average Lens Wear Time
Day 7
12.3 Hours
Standard Deviation 2.7
13.3 Hours
Standard Deviation 2.4
Average Lens Wear Time
Day 30
12.5 Hours
Standard Deviation 2.7
12.7 Hours
Standard Deviation 2.8
Average Lens Wear Time
Day 60
11.8 Hours
Standard Deviation 2.9
13.3 Hours
Standard Deviation 2.6
Average Lens Wear Time
Day 90
12.4 Hours
Standard Deviation 2.8
13.1 Hours
Standard Deviation 2.6

PRIMARY outcome

Timeframe: Up to Day 90

Population: This analysis population includes all randomized subjects.

No lens replacements were planned during the study. Lenses could be replaced as needed due to loss, damage, or as deemed necessary by the Investigator. If it became necessary to replace a lens, the subject was examined at an unscheduled visit. The counts in the table represent the total number of unscheduled lenses replaced by reason for any eye, any subject.

Outcome measures

Outcome measures
Measure
FID 120974A
n=71 Participants
Contact lens disinfecting solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Boston Simplus
n=35 Participants
Multi-action solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Number of Unscheduled Lens Replacements by Reason
Lost
3 lenses
1 lenses
Number of Unscheduled Lens Replacements by Reason
Lens torn on eye
0 lenses
1 lenses
Number of Unscheduled Lens Replacements by Reason
Lens torn while handling
1 lenses
0 lenses

PRIMARY outcome

Timeframe: Day 7, Day 30, Day 60, Day 90

Population: This analysis population includes all subjects with data at visit.

Lens comfort was assessed by the subject as a single response on a 5-point Likert scale (Strongly Agree, Agree, Undecided, Disagree, Strongly Disagree) to best describe their lens wearing experience over the last 3 days. Responses were summarized by agreement category and presented as percentage of subjects.

Outcome measures

Outcome measures
Measure
FID 120974A
n=69 Participants
Contact lens disinfecting solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Boston Simplus
n=35 Participants
Multi-action solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Likert Item - "When I Use This Solution, my Lenses Are Comfortable All Day."
Day 7, Strongly Agree
30.4 percentage of subjects
68.6 percentage of subjects
Likert Item - "When I Use This Solution, my Lenses Are Comfortable All Day."
Day 7, Agree
52.2 percentage of subjects
28.6 percentage of subjects
Likert Item - "When I Use This Solution, my Lenses Are Comfortable All Day."
Day 7, Undecided
7.2 percentage of subjects
0.0 percentage of subjects
Likert Item - "When I Use This Solution, my Lenses Are Comfortable All Day."
Day 7, Disagree
10.1 percentage of subjects
2.9 percentage of subjects
Likert Item - "When I Use This Solution, my Lenses Are Comfortable All Day."
Day 7, Strongly Disgree
0.0 percentage of subjects
0.0 percentage of subjects
Likert Item - "When I Use This Solution, my Lenses Are Comfortable All Day."
Day 30, Strongly Agree
31.9 percentage of subjects
68.6 percentage of subjects
Likert Item - "When I Use This Solution, my Lenses Are Comfortable All Day."
Day 30, Agree
47.8 percentage of subjects
28.6 percentage of subjects
Likert Item - "When I Use This Solution, my Lenses Are Comfortable All Day."
Day 30, Undecided
4.3 percentage of subjects
2.9 percentage of subjects
Likert Item - "When I Use This Solution, my Lenses Are Comfortable All Day."
Day 30, Disagree
13.0 percentage of subjects
0.0 percentage of subjects
Likert Item - "When I Use This Solution, my Lenses Are Comfortable All Day."
Day 30, Strongly Disagree
2.9 percentage of subjects
0.0 percentage of subjects
Likert Item - "When I Use This Solution, my Lenses Are Comfortable All Day."
Day 60, Strongly Agree
30.4 percentage of subjects
62.9 percentage of subjects
Likert Item - "When I Use This Solution, my Lenses Are Comfortable All Day."
Day 60, Agree
49.3 percentage of subjects
28.6 percentage of subjects
Likert Item - "When I Use This Solution, my Lenses Are Comfortable All Day."
Day 60, Undecided
8.7 percentage of subjects
0.0 percentage of subjects
Likert Item - "When I Use This Solution, my Lenses Are Comfortable All Day."
Day 60, Disagree
10.1 percentage of subjects
5.7 percentage of subjects
Likert Item - "When I Use This Solution, my Lenses Are Comfortable All Day."
Day 60, Strongly Disagree
1.4 percentage of subjects
2.9 percentage of subjects
Likert Item - "When I Use This Solution, my Lenses Are Comfortable All Day."
Day 90, Strongly Agree
30.4 percentage of subjects
54.3 percentage of subjects
Likert Item - "When I Use This Solution, my Lenses Are Comfortable All Day."
Day 90, Agree
50.7 percentage of subjects
28.6 percentage of subjects
Likert Item - "When I Use This Solution, my Lenses Are Comfortable All Day."
Day 90, Undecided
1.4 percentage of subjects
2.9 percentage of subjects
Likert Item - "When I Use This Solution, my Lenses Are Comfortable All Day."
Day 90, Disagree
15.9 percentage of subjects
11.4 percentage of subjects
Likert Item - "When I Use This Solution, my Lenses Are Comfortable All Day."
Day 90, Strongly Disagree
1.4 percentage of subjects
2.9 percentage of subjects

PRIMARY outcome

Timeframe: Day 7, Day 30, Day 60, Day 90

Population: This analysis population includes all subjects with data at visit.

Clear vision was assessed by the subject as a single response on a 5-point Likert scale (Strongly Agree, Agree, Undecided, Disagree, Strongly Disagree) to best describe their lens wearing experience over the last 3 days. Responses were summarized by agreement category and presented as percentage of subjects.

Outcome measures

Outcome measures
Measure
FID 120974A
n=69 Participants
Contact lens disinfecting solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Boston Simplus
n=35 Participants
Multi-action solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Likert Item - "When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear."
Day 60, Undecided
4.3 percentage of subjects
5.7 percentage of subjects
Likert Item - "When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear."
Day 7, Strongly Agree
37.7 percentage of subjects
48.6 percentage of subjects
Likert Item - "When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear."
Day 7, Agree
40.6 percentage of subjects
45.7 percentage of subjects
Likert Item - "When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear."
Day 7, Undecided
2.9 percentage of subjects
0.0 percentage of subjects
Likert Item - "When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear."
Day 7, Disagree
15.9 percentage of subjects
5.7 percentage of subjects
Likert Item - "When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear."
Day 7, Strongly Disagree
2.9 percentage of subjects
0.0 percentage of subjects
Likert Item - "When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear."
Day 30, Strongly Agree
29.0 percentage of subjects
48.6 percentage of subjects
Likert Item - "When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear."
Day 30, Agree
53.6 percentage of subjects
45.7 percentage of subjects
Likert Item - "When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear."
Day 30, Undecided
7.2 percentage of subjects
2.9 percentage of subjects
Likert Item - "When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear."
Day 30, Disagree
10.1 percentage of subjects
2.9 percentage of subjects
Likert Item - "When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear."
Day 30, Strongly Disagree
0.0 percentage of subjects
0.0 percentage of subjects
Likert Item - "When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear."
Day 60, Strongly Agree
33.3 percentage of subjects
57.1 percentage of subjects
Likert Item - "When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear."
Day 60, Agree
49.3 percentage of subjects
28.6 percentage of subjects
Likert Item - "When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear."
Day 60, Disagree
11.6 percentage of subjects
8.6 percentage of subjects
Likert Item - "When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear."
Day 60, Strongly Disagree
1.4 percentage of subjects
0.0 percentage of subjects
Likert Item - "When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear."
Day 90, Strongly Agree
29.0 percentage of subjects
45.7 percentage of subjects
Likert Item - "When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear."
Day 90, Agree
49.3 percentage of subjects
34.3 percentage of subjects
Likert Item - "When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear."
Day 90, Undecided
7.2 percentage of subjects
5.7 percentage of subjects
Likert Item - "When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear."
Day 90, Disagree
13.0 percentage of subjects
14.3 percentage of subjects
Likert Item - "When I Use This Solution, at the End of the Lens Wearing Day my Vision is Clear."
Day 90, Strongly Disagree
1.4 percentage of subjects
0.0 percentage of subjects

PRIMARY outcome

Timeframe: Day 7, Day 30, Day 60, Day 90

Population: This analysis population includes all subjects with data at visit.

Product handling was assessed by the subject as a single response on a 5-point Likert scale (Strongly Agree, Agree, Undecided, Disagree, Strongly Disagree) to best describe their lens wearing experience over the last 3 days. Responses were summarized by agreement category and presented as percentage of subjects.

Outcome measures

Outcome measures
Measure
FID 120974A
n=69 Participants
Contact lens disinfecting solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Boston Simplus
n=35 Participants
Multi-action solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Likert Item - "When I Use This Solution, I Like the Way This Product Feels During Handling."
Day 60, Disagree
2.9 percentage of subjects
0.0 percentage of subjects
Likert Item - "When I Use This Solution, I Like the Way This Product Feels During Handling."
Day 7, Strongly Agree
23.2 percentage of subjects
48.6 percentage of subjects
Likert Item - "When I Use This Solution, I Like the Way This Product Feels During Handling."
Day 7, Agree
50.7 percentage of subjects
40.0 percentage of subjects
Likert Item - "When I Use This Solution, I Like the Way This Product Feels During Handling."
Day 7, Undecided
20.3 percentage of subjects
8.6 percentage of subjects
Likert Item - "When I Use This Solution, I Like the Way This Product Feels During Handling."
Day 7, Disagree
5.8 percentage of subjects
2.9 percentage of subjects
Likert Item - "When I Use This Solution, I Like the Way This Product Feels During Handling."
Day 7, Strongly Disagree
0.0 percentage of subjects
0.0 percentage of subjects
Likert Item - "When I Use This Solution, I Like the Way This Product Feels During Handling."
Day 30, Strongly Agree
26.1 percentage of subjects
57.1 percentage of subjects
Likert Item - "When I Use This Solution, I Like the Way This Product Feels During Handling."
Day 30, Agree
53.6 percentage of subjects
34.3 percentage of subjects
Likert Item - "When I Use This Solution, I Like the Way This Product Feels During Handling."
Day 30, Undecided
13.0 percentage of subjects
8.6 percentage of subjects
Likert Item - "When I Use This Solution, I Like the Way This Product Feels During Handling."
Day 30, Disagree
5.8 percentage of subjects
0.0 percentage of subjects
Likert Item - "When I Use This Solution, I Like the Way This Product Feels During Handling."
Day 30, Strongly Disagree
1.4 percentage of subjects
0.0 percentage of subjects
Likert Item - "When I Use This Solution, I Like the Way This Product Feels During Handling."
Day 60, Strongly Agree
26.1 percentage of subjects
51.4 percentage of subjects
Likert Item - "When I Use This Solution, I Like the Way This Product Feels During Handling."
Day 60, Agree
56.5 percentage of subjects
34.3 percentage of subjects
Likert Item - "When I Use This Solution, I Like the Way This Product Feels During Handling."
Day 60, Undecided
14.5 percentage of subjects
11.4 percentage of subjects
Likert Item - "When I Use This Solution, I Like the Way This Product Feels During Handling."
Day 60, Strongly Disagree
0.0 percentage of subjects
2.9 percentage of subjects
Likert Item - "When I Use This Solution, I Like the Way This Product Feels During Handling."
Day 90, Strongly Agree
27.5 percentage of subjects
48.6 percentage of subjects
Likert Item - "When I Use This Solution, I Like the Way This Product Feels During Handling."
Day 90, Agree
52.2 percentage of subjects
40.0 percentage of subjects
Likert Item - "When I Use This Solution, I Like the Way This Product Feels During Handling."
Day 90, Undecided
11.6 percentage of subjects
5.7 percentage of subjects
Likert Item - "When I Use This Solution, I Like the Way This Product Feels During Handling."
Day 90, Disagree
7.2 percentage of subjects
2.9 percentage of subjects
Likert Item - "When I Use This Solution, I Like the Way This Product Feels During Handling."
Day 90, Strongly Disagree
1.4 percentage of subjects
2.9 percentage of subjects

PRIMARY outcome

Timeframe: Day 7, Day 30, Day 60, Day 90

Population: This analysis population includes all randomized subjects. Here, "n" is the total number of subjects with crystalline deposits in each treatment group, respectively, by visit.

Worn study lenses were removed and evaluated for deposits. Deposits found on the lenses were defined using a 3-part classification system consisting of general visibility, the specific appearance and area covered. Values were reported as a percentage of lens area covered. One eye (study eye) contributed to the analysis.

Outcome measures

Outcome measures
Measure
FID 120974A
n=71 Participants
Contact lens disinfecting solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Boston Simplus
n=35 Participants
Multi-action solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Crystalline Deposit Area Covered
Day 7, n=10, 5
18.0 percentage of lens area
Standard Deviation 16.2
19.0 percentage of lens area
Standard Deviation 18.2
Crystalline Deposit Area Covered
Day 30, n=17, 3
13.6 percentage of lens area
Standard Deviation 18.1
16.7 percentage of lens area
Standard Deviation 20.2
Crystalline Deposit Area Covered
Day 60, n=18, 8
11.9 percentage of lens area
Standard Deviation 14.1
7.0 percentage of lens area
Standard Deviation 3.5
Crystalline Deposit Area Covered
Day 90, n=21, 10
18.1 percentage of lens area
Standard Deviation 16.3
10.8 percentage of lens area
Standard Deviation 14.5

PRIMARY outcome

Timeframe: Day 7, Day 30, Day 60, Day 90

Population: This analysis population includes all randomized subjects. Here, "n" is the total number of subjects with film deposits in each treatment group, respectively, by visit.

Worn study lenses were removed and evaluated for deposits. Deposits found on the lenses were defined using a 3-part classification system consisting of general visibility, the specific appearance and area covered. Values were reported as a percentage of lens area covered. One eye (study eye) contributed to the analysis.

Outcome measures

Outcome measures
Measure
FID 120974A
n=71 Participants
Contact lens disinfecting solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Boston Simplus
n=35 Participants
Multi-action solution used with gas permeable contact lenses (study lenses) on a daily basis for 90 days
Film Deposit Area Covered
Day 7, n=40, 15
23.8 percentage of lens area
Standard Deviation 17.2
22.7 percentage of lens area
Standard Deviation 13.7
Film Deposit Area Covered
Day 30, n=47, 20
26.2 percentage of lens area
Standard Deviation 22.0
28.4 percentage of lens area
Standard Deviation 21.1
Film Deposit Area Covered
Day 60, n=47, 20
26.4 percentage of lens area
Standard Deviation 17.5
24.0 percentage of lens area
Standard Deviation 11.0
Film Deposit Area Covered
Day 90, n=45, 24
25.3 percentage of lens area
Standard Deviation 13.7
28.3 percentage of lens area
Standard Deviation 21.9

Adverse Events

Pre-treatment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

FID 120974A

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Boston Simplus

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Clinical Project Lead, GCRA

Alcon Research, Ltd.

Phone: 1-888-451-3937

Results disclosure agreements

  • Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
  • Publication restrictions are in place

Restriction type: OTHER